Calyx, formerly Parexel Informatics,[5] is a corporate spin-off from Parexel International.[2][6] Calyx is a British–American provider of biopharmaceutical services.[7] The company was formed in January 2021 following the strategic separation of the Parexel Informatics business from Parexel International, and provides medical imaging, e-clinical and regulatory services.[8]

References

  1. ^ https://www.calyx.ai/locations/
  2. ^ a b "Merck and Veeva Ink 10-Year Partnership Agreement". BioPharm International.
  3. ^ "Calyx Partnership with Top 5 CRO Extended through 2024". finance.yahoo.com.
  4. ^ "Company".
  5. ^ https://www.clinicalresearchnewsonline.com/news/2022/06/10/calyx-named-medical-imaging-provider-by-clinscience
  6. ^ "Calyx Spins Out of Parexel". Applied Clinical Trials Online.
  7. ^ "Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services".
  8. ^ "Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services". Retrieved 29 March 2023.